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Introduction
Helicobacter cinaedi is a Gram-negative spiral rod and was ﬁrst
isolated from rectum in homosexual men with proctocolitis in
1984 [1]. H. cinaedi inhabits the gastrointestinal tract of mammals.
H. cinaedi has been increasingly reported to cause many types of
infections, and has been isolated from both immunocompetent
and immunocompromised patients. Proctocolitis is ﬁrst reported
[1], however, more invasive diseases such as bacteremia, cellulitis,
arthritis, osteomyelitis, and meningitis have been recently
reported. Cellulitis among immunocompromised patients is often
multi-focal [2], however, among immunocompetent patients,
multi-focal cellulitis is rare. In the literature, approximately 30–
60% of patients have recurrent symptoms [3]. Longer antimicrobial
treatment may be required.
We report here an immunocompetent patient with H. cinaedi
bacteremia complicated with bilateral lower extremities skin and
soft tissue infections which was refractory to treat and required a
prolonged antimicrobial treatment.
Case report
A 54-year-old Japanese man with past medical history of
hypertension presented with one month history of fever, bilateral
lower extremities pain and erythema. The patient had been well
until approximately one month prior to admission, when he noted
fever, pain and redness in the bilateral lower extremities. He had
no history of injuries. Five days prior to admission, he was seen by
his primary care physician, and given a diagnosis of cellulitis in the
bilateral lower extremities. Two sets of blood culture were
obtained and oral levoﬂoxacin 500 mg daily was prescribed. Four
days later, blood cultures turned positive for Gram-negative spiral
rod. Then hewas admitted to our hospital for further investigation.
On admission, he had mild pain in the bilateral lower
extremities. He denied sore throat, running nose, fatigue, chills,
night sweats, weight changes, abdominal pain, nausea, vomiting,
diarrhea, dysuria, and frequency. He did not use illicit drugs. He
deniedhomosexual contact, any trauma, insectbites, or contactwith
animals. The temperature was 36.5 8C, the blood pressure was 157/
79 mmHg,and theheart ratewas51beats/min, respirations16/min.
He had symmetrical tenderness and erythema in the bilateral lower
dorsal part of the extremities (Fig. 1). The remainder of the physical
examinations was normal. The laboratory data showed the white
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A B S T R A C T
Helicobacter cinaedi is known to cause bacteremia with multi-focal cellulitis, usually, among
immunocompromised patients. We report here a 54-year-old Japanese man who was found to have
bacteremia complicated with bilateral lower extremities cellulitis due to H. cinaedi. This patient did not
have any immunocompromised conditions including Human Immunodeﬁciency Virus infection. In this
patient, the cellulitis was multi-focal which is rare among immunocompetent patients. In addition,
interestingly, the cellulitis was symmetrically on the both sides on the lower dorsal part of the
extremities. The patientwas treatedwithmeropenem,whichwas considered as one of the best available
agents, however, he required a prolonged antimicrobial treatment. During the admission, he underwent
colonoscopy which was unremarkable, and his stool culture was also negative while on meropenem.
Subsequently, he developed recurrent symptoms of the right lower extremity twice and each time he
was treated with intravenous meropenem followed by oral minocycline. After the total of 12 weeks of
antimicrobial treatment, his symptoms subsided. Clinicians should be aware of this organism when
treating multi-focal, or symmetrical cellulitis even [2_TD$DIFF] if the patients are immunocompetent.
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blood cell count was 8200/ml, neutrophils 73%, erythrocyte
sedimentation 46mm/h, otherwise unremarkable. Immunological
studies including immunoglobulin, complements were normal.
Human ImmunodeﬁciencyVirus (HIV) andHumanT-cell Lymphoma
Virus type-1 serology were both negative. CT of the lower
extremities without contrast was normal. Intravenous antimicro-
bial treatment with meropenem (1 g every 8 h) was started
empirically for Gram-negative spiral rod. The patient’s erythema
Table 1
Previously reported Helicobacter cinaedi infections, antimicrobial agents, and duration of the therapy.
Case
number
Author Year Age
(year)
Sex Medical history Site of infection Antimicrobial agents Duration of
treatment
1 Murata S 2015 56 Male Bronchial asthma Vertebral osteomyelitis
and bacteremia
Ceftriaxone 6 weeks
2 Haruki Y 2015 64 Male None Bacteremia, spondylitis,
diskitis
Cefazolin + fosfomycin 8 weeks
3 Mishima K 2015 48 Male Hepatitis C virus infection
induced liver cirrhosis,
diabetes mellitus,
hypertension
Bacteremia, cellulitis Cefazolin, relapse, cefazolin,
ciproﬂoxacin, minocycline
7 days, relapse,
4 months
4 Ishibashi R 2015 76 Female Slowly progressive type 1
diabetes, rheumatoid
arthritis
Bacteremia Cefepime, cefotiam,
minocycline
18 days
5 Ishibashi R 2015 47 Female Type 2 diabetes Bacteremia, cellulitis Cefazolin, cefdinir Not reported
6 Unosawa S 2015 79 Male Hypertension Infected abdominal
aortic aneurysm
Ampicillin/sulbactam,
gentamicin + ceftriaxone,
sultamicillin
4 months
7 Kakuta R 2014 64 Male Hypertension,
hyperlipidemia
Infected abdominal
aortic aneurysm
Ceftriaxone+ levoﬂoxacin,
doripenem+ vancomycin,
ampicillin/sulbactam
+minocycline,
amoxicillin +minocycline
More than 6 weeks
(not reported)
8 Kakuta R 2014 59 Male None Infected abdominal
aortic aneurysm
Piperacillin/tazobactam,
faropenem, piperacillin/
tazobactam, amoxicillin,
minocycline
More than 5 weeks
(not reported)
9 Kakuta R 2014 62 Male Myocardial infarction Infected abdominal
aortic aneurysm
Doripenem, amoxicillin,
minocycline
More than 4 weeks
(not reported)
10 Bartels H 2014 71 Male Polymyalgia rheumatica,
aortic stenosis
Endocarditis Amoxicillin/
clavulanate +gentamicin,
ceftriaxone+gentamicin
6 weeks
11 Sugiyama A 2014 34 Female Marfan syndrome,
schizophrenia
Meningitis Vancomycin +ceftriaxone,
meropenem
3 weeks
12 Kikuchi H 2012 31 Female Systemic lupus
erythematosus,
rheumatoid arthritis,
necrotizing fasciitis
Bacteremia, cellulitis Cefazolin + clindamycin,
pazuﬂoxacin, aztreonam,
relapse, aztreonam,
minocycline
18 days, relapse,
6 weeks
13 Kim SK 2012 71 Male Status post splenectomy,
immune hemolytic
anemia, aplastic anemia
Bacteremia Piperacillin/
tazobactam+ levoﬂoxacin
20 days
14 Holst H 2008 61 Male None Bacteremia, cellulitis Dicloxacillin, penicillin,
relapse, rifampicin
2 weeks, relapse,
2 weeks
15–25 Kitamura T 2007 22–79 2 male and
9 female
After the orthopedic
surgery
Bacteremia, cellulitis Sultamicillin, imipenem,
cefotiam
Not reported
26 Uc¸kay I 2006 53 Female Malignant lymphoma Bacteremia Ceftriaxone+gentamycin,
clarithromycin, levoﬂoxacin,
relapse,
ceftriaxone+doxycycline,
amoxicillin, metronidazole,
doxycycline
9 weeks, relapse,
3.5 months
27 Lasry S 2000 20 Male None Bacteremia, synovitis Ciproﬂoxacin+ rifampicin 12 weeks
28 Burman WJ 1995 26 Male Human
immunodeﬁciency virus
infection
Bacteremia Oxacillin/dicloxacillin,
oxacillin +gentamicin,
ciproﬂoxacin
31 days
29 Burman WJ 1995 39 Male Acquired immune
deﬁciency syndrome
Bacteremia Ciproﬂoxacin 21 days
30 Burman WJ 1995 56 Female Alcoholism Bacteremia Cefotetan,
clindamycin+gentamicin,
amoxicillin/clavulanate
18 days
31 Burman WJ 1995 27 Female Human
immunodeﬁciency virus
infection
Bacteremia Erythromycin, ciproﬂoxacin,
doxycycline
53 days
32 Burman WJ 1995 36 Male Acquired immune
deﬁciency syndrome
Bacteremia Cephalexin, ciproﬂoxacin,
doxycycline, ceftriaxone/
ceﬁxime
34 days
33 Burman WJ 1995 34 Male Acquired immune
deﬁciency syndrome
Bacteremia Ciproﬂoxacin 10 days
34 Burman WJ 1995 28 Male Acquired immune
deﬁciency syndrome
Bacteremia Ceftriaxone, ciproﬂoxacin,
doxycycline
42 days
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improved on the second day of admission. On the sixth day of
admission, the organism was identiﬁed as H. cinaedi by polymer-
ase chain reaction. The susceptibility testing showed as follows:
Ampicillin, imipenem, and gentamicin were susceptible. Clari-
thromycin and levoﬂoxacinwere resistant. Stool culture obtained
while he was on meropenem on the 10th day of admission was
negative. Abdominal ultrasound and esophagogastroduodeno-
scopy showed no signiﬁcant abnormalities. Colonoscopy showed
mild proctitis, however, biopsy specimen showed non-speciﬁc
inﬂammation. Transthoracic echocardiogram showed no vegeta-
tion. Intravenous meropenem 1 g every 8 h was administered for
14 days. The erythema and pain improved and he was discharged
home. Nineteen days after discharge, the patient came back with
right lower extremity erythema and pain. Hewas re-admitted and
meropenem 1 g every 8 h was restarted. Blood cultures and stool
cultures on admission were both negative. His symptoms
improved immediately after the initiation of treatment. Intrave-
nous meropenem was administered for four weeks and then
switched to oral minocycline 100 mg twice daily. However, two
weeks later, he was re-admitted due to the recurrent right lower
extremity pain. Repeated blood cultures this admission were
negative. Three week courses of intravenous meropenem was
administered followed by oralminocycline 100 mg twice daily for
3 weeks. After the two episodes of recurrence and subsequent
prolonged treatment, his symptoms subsided.
Discussion
Wereported a patientwith bacteremiawithmulti-focal skin and
soft tissue infections caused by H. cinaedi in an immunocompetent
patient which was refractory to treat with multiple recurrent
episodes. An increasing number of cases of H. cinaedi infection
among immunocompromisedpatients has been reportedduring the
last few decades, and it often causes bacteremia and cellulitis [4].
Recently, H. cinaedi infections among immunocompetent patients
are increasingly reported especially from Japan [5]. Cellulitis is often
multi-focal among immunocompromised patients [2], however,
among immunocompetent patients, multi-focal cellulitis is rare. H.
cinaedi resides in the gastrointestinal tract of mammals, and has an
ability to invade vascular systems [3], then causes bacteremia and
multi-focal cellulitis. Among patients with community-acquired H.
cinaedi bacteremia, more than 83.3% of the patients had apparent
cellulitis, while patients with healthcare associated H. cinaedi
bacteremia, only 43.8% of the patients had cellulitis (p = 0.078) [6].
On the basis of the previously reported case series [1–6], clinical
manifestations and severities are determined by the balance
between the host’s immune status and virulence of the organism.
The differences of the incidence of cellulitis above could be
explained by that the local inﬁltration of lymphocytes and
neutrophils might be inhibited in the immunocompromised
patients. That is, if patients with decreased immune systems may
have less symptoms including none or solitary cellulitis lesions. To
the contrary, patients with decreased immune systems tend to
develop severe cellulitis, while the competent immune systems can
prevent cellulitis to be multi-focal. The precise pathophysiology
of H. cinaedi bacteremic infection is not very well understood.
There are currently no standardized treatment in the literature
in selection and the duration of antimicrobial treatment for H.
cinaedi infection (Table 1). Approximately 30–60% of patients have
recurrent symptoms [3]. Carbapenems, aminoglycosides, and
tetracyclines showed low minimum inhibitory concentration
(MIC) values. Penicillins and cephalosporins showed moderate
MIC values. Macrolides, and quinolones showed high MIC values
[3]. The U.S. Centers for Disease Control and Prevention
recommends the two to six weeks of antimicrobial treatment,
however, recurrence can be seenwith these treatment. In addition,
patients who were treated with ﬂuoroquinolones may have more
recurrent episodes than those who were treated with other
antimicrobial agents [5]. This could be explained by the higher
MICs of ﬂuoroquinolones. In our case, recurrent symptoms were
observed in spite of the use of meropenem for several weeks;
therefore, we re-treated him for intravenous meropenem and oral
minocycline for a total of 12 weeks. Further study is needed to
determine the appropriate antimicrobial agent, the duration of the
antimicrobial treatment, and the pathogenesis of this infection and
its recurrence needs to be investigated.
In conclusion, clinicians should be aware of this microorganism
when treating patients with bilateral or multi-focal skin and soft
tissue infections even if he or she is immunocompetent.
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Fig. 1. Symmetrical erythema in the bilateral lower dorsal part of the extremities.
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